Lisa Lancaster
Assistant Professor of Medicine · Vanderbilt University Medical Center
Credentials: · · ·
History
Research
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
New England Journal of Medicine · 2014 · 3,144 citations
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
The Lancet · 2011 · 1,684 citations
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
Systematic review or meta-analysis · Nature Genetics · 2013 · 665 citations
- SN
25 papers
19 papers
17 papers
- PN
17 papers
17 papers
- JS
14 papers
- JL
13 papers
12 papers
Grants
- 2006–2007
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $2.3K · Vanderbilt University
Clinical trials
- 2018–2020
Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF)
Principal investigator · Terminated
Vanderbilt University Medical Center
- 2013–2017
Principal investigator · Completed · Phase 2
Kyntra Bio
- 2026
Study director · Recruiting · Phase 1
Endeavor Biomedicines, Inc.
- 2024–2026
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
Study director · Active not recruiting · Phase 2
Endeavor Biomedicines, Inc.